Serum Interferon-inducible Protein-10 is Associated with Replicative Status of Hepatitis D Virus, and Correlates with Hepatitis D RNA Levels, but does not Predict Treatment Outcome

被引：0
|
作者：
Hughes, Sarah A. [1 ]
Carey, Ivana [2 ]
Bruce, Matthew J. [1 ]
Horner, Mary [1 ]
Shang, Dazhuang [1 ]
Fletcher, Ian [1 ]
Suddlel, Abid [1 ]
Agarwal, Kosh [1 ]
Harrison, Phillip M. [2 ]
机构：
[1] Kings Coll Hosp, Inst Liver Studies, London, England
[2] Kings Coll London, Inst Liver Studies, London WC2R 2LS, England
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1867
引用
下载
收藏
页码：1062A / 1063A
页数：2
相关论文
共 50 条
  • [1] Hepatitis B virus infection and interferon-inducible protein-10
    Fabiani, S.
    CLINICA TERAPEUTICA, 2015, 166 (03): : E188 - E196
  • [2] Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels
    Itoh, Y
    Morita, A
    Nishioji, K
    Narumi, S
    Toyama, T
    Daimon, Y
    Nakamura, H
    Kirishima, T
    Okanoue, T
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (05) : 341 - 348
  • [3] Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B
    Wong, G. L. -H.
    Chan, H. L. -Y.
    Chan, H. -Y.
    Tse, C. -H.
    Chim, A. M. -L.
    Lo, A. O. -S.
    Wong, V. W. -S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) : 145 - 153
  • [4] Elevated serum levels of interferon-γ-inducible protein-10 in patients coinfected with hepatitis C virus and HIV
    Roe, Barbara
    Coughlan, Suzie
    Hassan, Jaythoon
    Grogan, Anne
    Farrell, Gillian
    Norris, Suzanne
    Bergin, Colm
    Hall, William W.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (07): : 1053 - 1057
  • [5] Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
    Jaroszewicz, Jerzy
    Ho, Huy
    Markova, Antoaneta
    Deterding, Katja
    Wursthorn, Karsten
    Schulz, Sandra
    Bock, Claus-Thomas
    Tillmann, Hans L.
    Manns, Michael P.
    Wedemeyer, Heiner
    Cornberg, Markus
    ANTIVIRAL THERAPY, 2011, 16 (06) : 915 - 924
  • [6] Interleukin-28B polymorphisms and interferon gamma inducible protein-10 serum levels in seronegative occult hepatitis C virus infection
    Bartolome, Javier
    Castillo, Inmaculada
    Antonio Quiroga, Juan
    Carreno, Vicente
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (02) : 268 - 274
  • [7] Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever
    Mahanty, S
    Bausch, DG
    Thomas, RL
    Goba, A
    Bah, A
    Peters, CJ
    Rollin, PE
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (12): : 1713 - 1721
  • [8] Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection
    Grebely, Jason
    Feld, Jordan J.
    Applegate, Tanya
    Matthews, Gail V.
    Hellard, Margaret
    Sherker, Alana
    Petoumenos, Kathy
    Zang, Geng
    Shaw, Ineke
    Yeung, Barbara
    George, Jacob
    Teutsch, Suzy
    Kaldor, John M.
    Cherepanov, Vera
    Bruneau, Julie
    Shoukry, Naglaa H.
    Lloyd, Andrew R.
    Dore, Gregory J.
    HEPATOLOGY, 2013, 57 (06) : 2124 - 2134
  • [9] SERUM LEVELS OF INTERFERON-GAMMA INDUCIBLE PROTEIN (IP-)10 ARE ASSOCIATED WITH RESPONSE TO PEGINTERFERON TREATMENT IN GENOTYPE D HBEAG-NEGATIVE CHRONIC HEPATITIS B
    Arends, Pauline
    Sonneveld, Milan J.
    Hansen, Bettina E.
    Groothuismink, Zwier M.
    Boonstra, Andre
    Janssen, Harry L.
    HEPATOLOGY, 2011, 54 : 1019A - 1019A
  • [10] Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection
    Khalifa, K. A.
    Radwan, W. M.
    Attallah, K. M.
    Hosney, H.
    Eed, E. M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2014, 77 (04): : 401 - 407
12345